Orions Rhapsody broadens NHS connectivity

Orion Health, an Auckland, New Zealand-based developer of integration and clinical workflow technology, said that its Rhapsody Integration Engine continues to be adopted by National Health Service (NHS) Trusts in the United Kingdom. In the past three months, Rhapsody has been adopted or deployed by three acute NHS Trusts representing seven hospital sites, 11,300 employees, and more than one million patients, according to Orion.

East Lancashire Hospitals NHS Trust and the Robert Jones and Agnes Hunt Orthopedic and District Hospital NHS Trust have both adopted Rhapsody as a Trust integration engine. In addition, Northampton General Hospital NHS Trust has recently completed deployment of Rhapsody to manage integration to their systems.

The East Lancashire Hospitals NHS Trust facilities plan to use Rhapsody to connect multiple hospital systems, including the patient administration system (PAS), pathology, PACS, pharmacy and radiology.

Robert Jones and Agnes Hunt Orthopedic and District Hospital NHS Trust is using Rhapsody to transfer radiology reports from its newly implemented RIS to local general practitioners and into the Trust's electronic patient record.

Northampton General Hospital NHS Trust has implemented Rhapsody to provide inter-system messaging across clinical systems including its PAS, radiology, pathology, results reporting, and local clinical databases. Rhapsody is currently processing 6,500 PAS messages daily in Northampton, according to Orion.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.